• Contact: +91-9643310025, 9643312749
  • Generic selectors
    Exact matches only
    Search in title
    Search in content
    Search in posts
    Search in pages
    Filter by Categories
    Annual brand plans
    Autoimmune diseases
    Blog
    Conference support
    Corporate strategy and R & D consulting
    KOL support
    Medical
    MSL training
    Orphan Diseases
    Pre-& post launch activities
    Sales & marketing
    Sales force training
Pharmintel

Clinical development for COVID 19 in 2020

Posted by pharmintel on March 24, 2020

0
Category: Blog
A Phase 1 of clinical trial has begun at Kaiser Permanente Washington Health Research Institute in Seattle to evaluate an investigational vaccine designed to protect against the novel Coronavirus disease (COVID-19) The NIAID, a part of the National Institutes of Health, is funding the trial. The study is just to analyze the safety level by evaluating different doses of the experimental vaccine and its ability to induce an immune response in patients. It is the first

Coronavirus: A Threat to Indian Generic Drug Industry

Posted by pharmintel on February 22, 2020

0
Category: Blog
The outbreak of CORONAVIRUS and severe travel restrictions to stop its spread has taken a huge leap on the world’s second-largest economy and disrupted several industries dependant on Chinese supplies. India procures about 70 percent of API (active pharmaceutical ingredient) from China. The Indian pharma inventories have stock for a very short term and if travel restrictions continue conditions will worsen. Indian government is taking major steps to encourage domestic production of API’s to counter

CORONAVIRUS PIPELINE: ARE WE READY WITH DRUGS/VACCINES?

Posted by pharmintel on February 21, 2020

0
Category: Blog
The novel coronavirus outbreak in China, Wuhan has been termed as Covid-19, is spreading rapidly to other countries and millions of lives are endangered. This pandemic has catalyzed the development of novel coronavirus vaccines in the industry and several companies are coming up with treatment and therapy for this deadly virus. Recently Favilavir, an anti-viral drug, as a treatment for Coronavirus has been approved by the National Medical Products Administration of China. The drug reportedly has

Sales Target

Posted by pharmintel on February 17, 2020

0
Category: Blog
It’s an important factor for sales personals to accomplish sales target. Sales target plays an important role in companies’ annual turnover, market share, profitability, number of new account and renewal of existing contracts, etc. Sales target is the driving factor of company’s growth but under performing sales employees make it vulnerable. For most of the sales employees it becomes a tedious job to meet targets which are exceeding limits. To understand how to beat sales
Tagrisso does not meet the criteria set up by NICE’s to be considered as a life-extending treatment. Data suggest that patients who take Tagrisso live longer than their peers who receive Roche’s Tarceva (erlotinib) or AstraZeneca’s own Iressa (gefitinib). However, AstraZeneca was not able to share any information from a randomized clinical trial comparing Tagrisso to Boehringer Ingelheim’s Gilotrif (afatinib) which is the first choice, EGFR tyrosine kinase inhibitor and this may prove to be
Contact
+91 9643310025, 9643312749
© 2020 Pharmintel